Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial

Mowat C., Arnott I., Cahill A., Smith M., Ahmad T., Subramanian S., Travis S., Morris J., Hamlin J., Dhar A., Nwokolo C., Edwards C., Creed T., Bloom S., Yousif M., Thomas L., Campbell S., Lewis SJ., Sebastian S., Sen S., Lal S., Hawkey C., Murray C., Cummings F., Goh J., Lindsay JO., Arebi N., Potts L., McKinley AJ., Thomson JM., Todd JA., Collie M., Dunlop MG., Mowat A., Gaya DR., Winter J., Naismith GD., Ennis H., Keerie C., Lewis S., Prescott RJ., Kennedy NA., Satsangi J.

DOI

10.1016/s2468-1253(16)30078-4

Type

Journal article

Journal

The Lancet Gastroenterology & Hepatology

Publisher

Elsevier BV

Publication Date

12/2016

Volume

1

Pages

273 - 282

Permalink Original publication